Tvardi Therapeutics Inc (TVRD)

Finanzdaten der Tvardi Therapeutics Inc-Aktie (TVRD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	5.98%6.63	7.05	7.59	5.94	8.87
Research and Development	18.51%4.00	4.91	5.49	3.60	5.81
Operating Income/Loss	5.98%-6.63	-7.05	-7.59	-5.94	-8.87
Income Tax Expense/Benefit, Current	-	-	-	-	-
Income Tax Expense/Benefit, Deferred	-	-	-	-	-
	5.10%-6.46	-6.80	-7.28	-5.53	4.17
Attributable To Parent	5.10%-6.46	-6.80	-7.28	-5.53	4.17
Available To Common Stockholders, Basic	5.10%-6.46	-6.80	-7.28	-5.53	4.17
Basic Average Shares	9.38	9.38	-	9.38	8.25
Diluted Average Shares	9.38	9.38	-	9.38	8.46
Basic Earnings Per Share	5.48%-0.69	-0.73	-	-0.59	0.51
Diluted Earnings Per Share	5.48%-0.69	-0.73	-	-0.59	-1.00
Common Stock Dividends	-	-	-	-	-